• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物及相关物质中杂质概况的评估。第11部分——色谱法和光谱法在药物合成中副反应评估中的作用。

Estimation of impurity profiles in drugs and related materials. Part 11--The role of chromatographic and spectroscopic methods in the estimation of side-reactions in drug syntheses.

作者信息

Görög S, Balogh G, Csehi A, Csizér E, Gazdag M, Halmos Z, Hegedüs B, Herényi B, Horváth P, Laukó A

机构信息

Chemical Works of G. Richter Ltd., Budapest, Hungary.

出版信息

J Pharm Biomed Anal. 1993 Nov-Dec;11(11-12):1219-26. doi: 10.1016/0731-7085(93)80107-c.

DOI:10.1016/0731-7085(93)80107-c
PMID:8123737
Abstract

Impurities in drugs are classified on the basis of the types of side-reactions in drug syntheses resulting in their formation. This is shown by summarizing the authors' earlier results in the field of impurity profiling of 19-nor-steroids, ethynodiol diacetate, mazipredone, pipecuronium bromide, flumecinol, enalapril, pyridinol carbamate, phenylbutazone, thymotrinan and some new results related to danazol and famotidine.

摘要

药物中的杂质根据药物合成中导致其形成的副反应类型进行分类。这通过总结作者早期在19-去甲甾体、炔诺二醇二乙酸酯、马齐泼酮、哌库溴铵、氟美西诺、依那普利、吡啶醇氨基甲酸酯、保泰松、胸腺三肽领域的杂质分析结果以及与达那唑和法莫替丁相关的一些新结果得以体现。

相似文献

1
Estimation of impurity profiles in drugs and related materials. Part 11--The role of chromatographic and spectroscopic methods in the estimation of side-reactions in drug syntheses.药物及相关物质中杂质概况的评估。第11部分——色谱法和光谱法在药物合成中副反应评估中的作用。
J Pharm Biomed Anal. 1993 Nov-Dec;11(11-12):1219-26. doi: 10.1016/0731-7085(93)80107-c.
2
Estimation of impurity profiles of drugs and related materials: part XXI. HPLC/UV/MS study of the impurity profile of ethynodiol diacetate.
J Pharm Biomed Anal. 2002 Aug 1;29(6):1153-7. doi: 10.1016/s0731-7085(02)00165-6.
3
Estimation of impurity profiles of drugs and related materials: part 19: theme with variations. Identification of impurities in 3-oxosteroids.
J Pharm Biomed Anal. 1998 Dec;18(4-5):511-25. doi: 10.1016/s0731-7085(98)00206-4.
4
Estimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol.药物及相关物质杂质概况的评估。12. 达那唑中一种异构体杂质的分离与鉴定。
Pharm Res. 1995 Feb;12(2):295-8. doi: 10.1023/a:1016201630774.
5
Estimation of impurity profiles of drugs and related materials. Part VIII: Combined application of high-performance liquid chromatography and NMR spectroscopy in the impurity profiling of drugs.药物及相关物质杂质概况的评估。第八部分:高效液相色谱法和核磁共振光谱法在药物杂质概况分析中的联合应用。
J Pharm Biomed Anal. 1991;9(10-12):829-33. doi: 10.1016/0731-7085(91)80009-x.
6
Forced degradation and impurity profiling: recent trends in analytical perspectives.强制降解和杂质剖析:分析视角的最新趋势。
J Pharm Biomed Anal. 2013 Dec;86:11-35. doi: 10.1016/j.jpba.2013.07.013. Epub 2013 Jul 31.
7
[Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
Acta Pharm Hung. 2000 Jul-Dec;70(3-6):131-7.
8
Chemical and analytical characterization of related organic impurities in drugs.药物中相关有机杂质的化学和分析表征
Anal Bioanal Chem. 2003 Nov;377(5):852-62. doi: 10.1007/s00216-003-2140-6. Epub 2003 Aug 23.
9
Estimation of impurity profiles of drugs and related materials. Part 9: HPLC investigation of flumecinol.药物及相关物质的杂质概况评估。第9部分:氟米西诺的高效液相色谱研究。
J Pharm Biomed Anal. 1992 Oct-Dec;10(10-12):831-5. doi: 10.1016/0731-7085(91)80088-q.
10
Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices.药物及相关物质杂质概况的评估。第14部分:高效液相色谱/二极管阵列紫外光谱法在鉴定各种基质中次要成分(杂质、降解产物、代谢物)方面的作用。
J Pharm Biomed Anal. 1995 Dec;14(1-2):85-92. doi: 10.1016/0731-7085(95)01579-5.

引用本文的文献

1
Estimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol.药物及相关物质杂质概况的评估。12. 达那唑中一种异构体杂质的分离与鉴定。
Pharm Res. 1995 Feb;12(2):295-8. doi: 10.1023/a:1016201630774.